Skip to main content
PeptiDex Logo

PeptiDex

Peptide Research Index

Research-backed

⚠️ Educational only · Not medical advice · Consult a doctor · Most peptides are research-only / not FDA-approved for human use

Privacy & Terms
Home
Library
StartToolsSaved
All Blends
🛡️

BPC-157 / KPV

"The Gut Healer"

BPC-157KPVGut Health

Benefits

Gut healing, IBD relief, reduced intestinal inflammation, mucosal repair

Why This Blend?

BPC-157's tissue repair meets KPV's potent NF-κB suppression. BPC-157 heals the physical damage while KPV turns off the inflammatory signaling causing it. The ultimate gut restoration protocol.

Mechanism of Action

BPC-157 promotes GI mucosal healing via cytoprotective pathways and angiogenesis. KPV (alpha-MSH fragment) powerfully suppresses NF-κB inflammatory signaling and reduces pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) in intestinal epithelium.

Dosing Protocol

Typical Ratio: BPC-157 500mcg + KPV 200-500mcg

BPC-157 250-500mcg SubQ + KPV 200-500mcg orally or SubQ. KPV oral capsules target gut directly. Cycle 4-12 weeks.

Expected Timeline

Week 1

Rapid reduction in gut inflammation; improved GI comfort

Weeks 2–4

Mucosal healing; reduced bloating and IBS/IBD symptoms

Months 2–3

Significant GI restoration; normalized bowel function

Long-term

Sustained gut health; potential remission of chronic GI conditions

Supporting Studies

BPC-157 GI tract healing

BPC-157 heals GI ulcers, fistulas, and inflammatory bowel lesions.

preclinical

KPV anti-inflammatory effects in colitis

KPV suppresses NF-κB and MAPK pathways in inflammatory bowel disease models.

preclinical

Safety Notes

Both peptides have excellent safety profiles. KPV can be taken orally for gut-specific effects. Not FDA-approved.

📚 Individual Peptide Profiles

BPC-157 →KPV →